Eliem Therapeutics Inc — Company Overview, News & Financial Data

Eliem Therapeutics (NASDAQ: ELYM) is focused on developing treatments that address debilitating and chronic neurological and psychiatric conditions. The company's pipeline includes candidates targeting chronic pain, depression, and epilepsy, aiming to improve the quality of life for those suffering from these conditions. Eliem is advancing its proprietary therapies through clinical trials, leveraging innovative research to deliver novel solutions to unmet medical needs. With an emphasis on patient-centric development, Eliem collaborates with scientific communities and healthcare professionals to ensure its therapies meet the highest standards of efficacy and safety. Their ultimate objective is to bring groundbreaking treatments to market, transforming patient experiences and outcomes in meaningful ways.